Hematology/Oncology

Top Story

Lymphoma survivors face increased risk for cardiac problems after HSCT

July 29, 2015

Left ventricular systolic dysfunction and heart failure occurred more frequently than previously reported in adult survivors of lymphoma who underwent autologous hematopoietic stem cell transplantation, according to study results.

Researchers identified several risk factors for left ventricular systolic dysfunction (LVSD) in this population, which could serve as a basis for targeted surveillance.

In the Journals

What are the benefits vs. risks of contralateral prophylactic mastectomy?

July 29, 2015
Women diagnosed with cancer in one breast often decide to undergo contralateral prophylactic mastectomy — or the removal of the other cancer-free breast — as…
In the Journals

Oncologists criticize high drug costs, propose cost-cutting measures

July 28, 2015
Over 100 U.S. oncologists have issued a statement deriding the high cost of cancer drugs and calling for new regulations to mitigate expenses.Authors of the statement…
Brennan Spiegel, MD In the Journals

Latinos, blacks with family history of CRC less likely to receive colonoscopy than whites

July 28, 2015
Among individuals with a family history of colorectal cancer, Latinos and blacks were less likely to undergo guideline-recommended screening colonoscopy compared with…
FDA News

FDA grants breakthrough therapy designation to Azedra for pheochromocytoma, paraganglioma

July 28, 2015
The FDA granted breakthrough therapy designation to Ultratrace iobenguane I-131 for the treatment of patients with iobenguane-avid metastatic or recurrent…
More News Headlines »
CME
Hematology Oncology Case Consults

The Patient with Chronic Lymphocytic Leukemia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with chronic lymphocytic leukemia.
More »
Meeting News Coverage Video
VIDEO: 'Care paths' may help manage rising cancer costs

VIDEO: 'Care paths' may help manage rising cancer costs

June 19, 2015
CHICAGO — Brian Bolwell, MD, chairman of Taussig Cancer Institute at Cleveland Clinic, discusses an abstract on…
More »
CME
Immunotherapy Updates 2015: FOCUS on NSCLC

Immunotherapy Updates 2015: FOCUS on NSCLC

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
morganatic-roan